Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
GrafTech
EAF
$195M
| $274K | ﹤0.01% |
7,163
-394
| -5% | -$16.5K |
|
3027
Enviri
NVRI
$651M
| $274K | ﹤0.01% |
37,889
-3,158
| -8% | -$25.5K |
|
|
TERN
3028
DELISTED
Terns Pharmaceuticals
TERN
| $273K | ﹤0.01% |
54,327
-208,591
| -79% | -$1.32M |
|
3029
CleanSpark
CLSK
$3.76B
| $273K | ﹤0.01% |
71,536
+23,689
| +50% | +$125K |
|
3030
Cytek Biosciences
CTKB
$557M
| $271K | ﹤0.01% |
49,179
+411
| +0.8% | +$3.3K |
|
3031
DXP Enterprises
DXPE
$2.53B
| $271K | ﹤0.01% |
7,748
-2,081
| -21% | -$75.1K |
|
|
TPC
3032
Tutor Perini Cor
TPC
$4.51B
| $270K | ﹤0.01% |
34,456
+15,262
| +80% | +$125K |
|
|
WW
3033
DELISTED
WW International
WW
| $269K | ﹤0.01% |
24,337
+3,316
| +16% | +$32.6K |
|
3034
HCI Group
HCI
$2.29B
| $269K | ﹤0.01% |
4,962
+1,754
| +55% | +$99.7K |
|
3035
First Advantage
FA
$3.5B
| $269K | ﹤0.01% |
19,518
-5,668
| -23% | -$82.3K |
|
3036
Teekay Tankers
TNK
$2.79B
| $269K | ﹤0.01% |
6,459
-1,311
| -17% | -$53.5K |
|
3037
Ardmore Shipping
ASC
$712M
| $268K | ﹤0.01% |
20,591
+12,397
| +151% | +$160K |
|
3038
Symbotic
SYM
$5.83B
| $268K | ﹤0.01% |
8,008
+5,298
| +195% | +$218K |
|
3039
Arbutus Biopharma
ABUS
$861M
| $268K | ﹤0.01% |
131,845
+83,950
| +175% | +$176K |
|
|
SNBR
3040
DELISTED
Sleep Number
SNBR
| $268K | ﹤0.01% |
10,881
-101
| -0.9% | -$2.83K |
|
|
AIMAU
3041
DELISTED
Aimfinity Investment Corp I Unit
AIMAU
| $267K | ﹤0.01% |
25,000
| – | – |
|
3042
Oportun Financial
OPRT
$267M
| $267K | ﹤0.01% |
36,952
+21,071
| +133% | +$139K |
|
3043
Mesa Laboratories
MLAB
$584M
| $267K | ﹤0.01% |
2,537
-460
| -15% | -$58.9K |
|
|
TEAD
3044
Teads Holding Co
TEAD
$78.8M
| $266K | ﹤0.01% |
54,544
+9,848
| +22% | +$52K |
|
3045
Orrstown Financial Services
ORRF
$859M
| $266K | ﹤0.01% |
12,639
-497
| -4% | -$10.8K |
|
|
TSE
3046
DELISTED
Trinseo
TSE
| $266K | ﹤0.01% |
32,501
+8,497
| +35% | +$108K |
|
3047
World Acceptance Corp
WRLD
$877M
| $265K | ﹤0.01% |
2,086
+190
| +10% | +$26.2K |
|
3048
Western New England Bancorp
WNEB
$263M
| $265K | ﹤0.01% |
40,838
+4,948
| +14% | +$31.3K |
|
3049
Transcat
TRNS
$838M
| $265K | ﹤0.01% |
2,705
-264
| -9% | -$25.2K |
|
3050
Criteo S.A. Ordinary Shares
CRTO
$1.07B
| $264K | ﹤0.01% |
9,046
-24,695
| -73% | -$758K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.